It’s not just disease that’s dragged down the nation’s life expectancy.
Since a catastrophic explosion in September, delays have lost the company work to a European rival.
Softbank and Foxconn both plan to broaden their American operations, and the president-elect is happy to take credit.
A majority of patients in a small clinical trial have been in remission from a deadly type of cancer for more than four years.
People voice concerns about drugs via search queries—and that data that can predict when one might be recalled.
The popular portrayal of computers as magic boxes capable of anything has done real societal harm. Now one TV show wants to save us.
Many genetic conditions come with clues in a person’s face, and new technology can help doctors diagnose them.
You can simply scan your phone, pick your food up off the shelf, and walk out.
Pay-as-you-go solar systems have begun to light up homes in underserved parts of the continent, but will need to pack more punch to leapfrog the grid.
Companies are racing to develop a new type of cancer therapy, but scientists are still assessing its safety.